Assembly-defective point mutants of the human immunodeficiency virus type 1 Gag precursor phenotypically expressed in recombinant baculovirus-infected cells
about
Characterization of a novel type of HIV-1 particle assembly inhibitor using a quantitative luciferase-Vpr packaging-based assayEfficient production of HIV-1 virus-like particles from a mammalian expression vector requires the N-terminal capsid domainCharacterization of deletion mutations in the capsid region of human immunodeficiency virus type 1 that affect particle formation and Gag-Pol precursor incorporation.Baculovirus display of single chain antibody (scFv) using a novel signal peptideAnalysis of minimal human immunodeficiency virus type 1 gag coding sequences capable of virus-like particle assembly and release.Role of the Gag matrix domain in targeting human immunodeficiency virus type 1 assembly.Human immunodeficiency virus type 1 Gag polyprotein multimerization requires the nucleocapsid domain and RNA and is promoted by the capsid-dimer interface and the basic region of matrix protein.Virus maturation by budding.Antiviral activity of recombinant ankyrin targeted to the capsid domain of HIV-1 Gag polyprotein.Multi-step inhibition explains HIV-1 protease inhibitor pharmacodynamics and resistance.Pericentriolar Targeting of the Mouse Mammary Tumor Virus GAG Protein.Human immunodeficiency virus type 1 MA deletion mutants expressed in baculovirus-infected cells: cis and trans effects on the Gag precursor assembly pathway.Linker insertion mutations in the human immunodeficiency virus type 1 gag gene: effects on virion particle assembly, release, and infectivity.Sequence requirements for encapsidation of deletion mutants and chimeras of human immunodeficiency virus type 1 Gag precursor into retrovirus-like particles.A molecular determinant of human immunodeficiency virus particle assembly located in matrix antigen p17.Incorporation of Pr160(gag-pol) into virus particles requires the presence of both the major homology region and adjacent C-terminal capsid sequences within the Gag-Pol polyprotein.Effects of nucleocapsid mutations on human immunodeficiency virus assembly and RNA encapsidationPhenotypic characterization of insertion mutants of the human immunodeficiency virus type 1 Gag precursor expressed in recombinant baculovirus-infected cells.Specificity and sequence requirements for interactions between various retroviral Gag proteins.Characterization of virus-like particles produced by the expression of rotavirus capsid proteins in insect cellsA novel platform for virus-like particle-display of flaviviral envelope domain III: induction of Dengue and West Nile virus neutralizing antibodiesThe role of nucleocapsid and U5 stem/A-rich loop sequences in tRNA(3Lys) genomic placement and initiation of reverse transcription in human immunodeficiency virus type 1.Structural consequences of cyclophilin A binding on maturational refolding in human immunodeficiency virus type 1 capsid protein.The NH2-terminal domain of the human T-cell leukemia virus type 1 capsid protein is involved in particle formation.Effect of mutations in the nucleocapsid protein (NCp7) upon Pr160(gag-pol) and tRNA(Lys) incorporation into human immunodeficiency virus type 1.Incorporation of human immunodeficiency virus type 1 Gag proteins into murine leukemia virus virions.
P2860
Q28477791-F12C591E-C67C-4093-A298-FDBC013C7A8EQ28478202-56AF6974-A338-4B68-A8BE-8D1FFB037257Q30452616-F2BA81F0-503A-4C5C-94EA-960D95B29886Q33751786-0AD0A4E4-8F04-4FA9-A2E4-FB80F9DFECE1Q33784754-2F6E2154-47CD-400E-8DC0-3F79B91789A0Q33800293-15EB63C6-4BCF-40A9-9AE0-70B2F5F84C97Q33820522-3B7C7924-676C-4FA7-8D10-75F3115551DAQ34068037-8DEBEF05-FA7A-4E42-A0C3-E3FC773C2213Q34163977-5FCD8EAE-6CE8-4BE3-8DDA-26F459F9EF01Q35237575-2A301C63-3FF3-41F2-9F02-EE79E2E79D22Q35677142-40BFEBBA-886E-4DA1-AADA-CEE846E5018BQ35829873-4EE3B1DD-E068-4D80-A37D-80F98DC70A45Q35830898-C1D48866-D8F9-4CBB-8D4B-F0513A42FFCDQ35837753-6F2FCF97-3249-4479-A9EB-B70DE0AD9EE2Q35842199-216A4D3E-039A-4230-BE81-2CA228213CA2Q35886606-636E8402-80A1-4B3A-AC64-5AD23AB5096BQ35891833-45C12E33-7AD0-4B1D-9C7D-DF397401F64AQ36619015-F45B6027-FD1F-4A3C-83FD-3121115E7CB1Q36626107-79B53AA3-DB5C-4170-A089-2345D9C04708Q36635294-340C0BA0-0826-4C90-A972-6F15511F5A48Q36889041-B42E58E1-DB58-409A-9E6F-D231ED22C47FQ39578385-F109BFEB-977D-40A5-8697-696C3B24D193Q39602742-B3D27F38-5B8B-48D6-8053-4D8F879DF2C8Q39606189-088E8679-0B6E-4682-A1E1-594218F9D3E5Q39879855-80BE4ABD-2E6B-4AB9-ABDB-8376E04AD58BQ40047853-58883E9D-A15A-4CB5-BC3E-EB30A611222D
P2860
Assembly-defective point mutants of the human immunodeficiency virus type 1 Gag precursor phenotypically expressed in recombinant baculovirus-infected cells
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
1993年论文
@zh
1993年论文
@zh-cn
name
Assembly-defective point mutan ...... ant baculovirus-infected cells
@ast
Assembly-defective point mutan ...... ant baculovirus-infected cells
@en
type
label
Assembly-defective point mutan ...... ant baculovirus-infected cells
@ast
Assembly-defective point mutan ...... ant baculovirus-infected cells
@en
prefLabel
Assembly-defective point mutan ...... ant baculovirus-infected cells
@ast
Assembly-defective point mutan ...... ant baculovirus-infected cells
@en
P2860
P1433
P1476
Assembly-defective point mutan ...... ant baculovirus-infected cells
@en
P2093
P2860
P304
P407
P577
1993-05-01T00:00:00Z